Inventor · disambiguated record
Harry G. Brittain
Also filed as: BRITTAIN HARRY · BRITTAIN HARRY G
28 granted patents·18 pending applications·221 citations·filing 1986–2024
96Inventor score
Files withTHEAPRIN PHARMACEUTICALS INC22ALKERMES PHARMA IRELAND LTD6BRITTAIN HARRY G6ALKERMES INC4BARD INC C R2
Top patents by PatentIndex Score
46 records- 0195US8173625B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineBRITTAIN HARRY G·Filed 2009·Granted May 8, 2012·32 cites·8 claims
- 0294US9603937B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2015·Granted Mar 28, 2017·6 cites·3 claims
- 0391US8304404B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineBRITTAIN HARRY G·Filed 2012·Granted Nov 6, 2012·10 cites·10 claims
- 0490US9603938B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·3 claims
- 0590US4861727ALuminescent oxygen sensor based on a lanthanide complexBARD INC C R·Filed 1986·Granted Aug 29, 1989·94 cites·43 claims
- 0689US12268783B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2021·Granted Apr 8, 2025·1 cites·4 claims
- 0789US9603939B2Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·3 claims
- 0888US8975272B2Polymorphic forms of naltrexoneALKERMES INC·Filed 2014·Granted Mar 10, 2015·2 cites·4 claims
- 0988US2025228778A1Platform drug delivery system utilizing crystal engineering and theanine dissolutionTHEAPRIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1086US10166228B2Polymorphic forms of naltrexoneALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Jan 1, 2019·2 cites·4 claims
- 1184US8735420B2Polymorphic forms of naltrexoneALKERMES INC·Filed 2012·Granted May 27, 2014·1 cites·12 claims
- 1284US7279579B2Polymorphic forms of naltrexoneALKERMES INC·Filed 2004·Granted Oct 9, 2007·4 cites·5 claims
- 1382US9556189B2Polymorphic forms of naltrexoneALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Jan 31, 2017·1 cites·4 claims
- 1482US5190729ALuminescent oxygen sensor based on a lanthanide complexBARD INC C R·Filed 1991·Granted Mar 2, 1993·51 cites·16 claims
- 1581US9289440B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Granted Mar 22, 2016·2 cites·14 claims
- 1681US8685948B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2013·Granted Apr 1, 2014·2 cites·16 claims
- 1780US9289438B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineBRITTAIN HARRY G·Filed 2014·Granted Mar 22, 2016·2 cites·16 claims
- 1880US9289439B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineBRITTAIN HARRY G·Filed 2014·Granted Mar 22, 2016·2 cites·16 claims
- 1980US8476250B2Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2013·Granted Jul 2, 2013·2 cites·24 claims
- 2079US8389540B2Polymorphic forms of naltrexoneBRITTAIN HARRY G·Filed 2007·Granted Mar 5, 2013·1 cites·12 claims
- 2176US2025134912A1Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of useTHEAPRIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2275US9827240B2Polymorphic forms of naltrexoneALKERMES PHARMA IRELAND LTD·Filed 2016·Granted Nov 28, 2017·0 cites·4 claims
- 2375US2023111210A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2475US2023115710A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate ,and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2575US2023201147A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2675US2023201152A1Cocrystal antioxidants of protocatechuic acid with l-theanine for the treatment of oxidative stress and inflammatory conditionsTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2775US2023110872A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2873US10328070B1Polymorphic forms of naltrexoneALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Jun 25, 2019·0 cites·4 claims
- 2971US9980958B2Polymorphic forms of naltrexoneALKERMES PHARMA IRELAND LTD·Filed 2017·Granted May 29, 2018·0 cites·4 claims
- 3071US2023149427A1Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of useTHEAPRIN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3170US9221830B2Polymorphic forms of naltrexoneALKERMES INC·Filed 2015·Granted Dec 29, 2015·0 cites·4 claims
- 3270US2024041790A1Topical antisepticSURGIWIPE LLC·Filed 2023·Application pending·0 cites
- 3370US2024058492A1Nasal antisepticPOVINEZ LLC·Filed 2023·Application pending·0 cites
- 3468US9365580B2Polymorphic forms of naltrexoneALKERMES PHARMA IRELAND LTD·Filed 2015·Granted Jun 14, 2016·0 cites·4 claims
- 3567US2014296189A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3667US2014343021A1Adjuvant to thrombolytic therapy for the treatment of frostbiteTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3767US2014235594A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3865US2020376004A1Amorphous onapristone compositions and methods of making the sameCONTEXT BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3964US2018064649A1Platform drug delivery system utilizing crystal engineering and theanine dissolutionBRITTAIN HARRY G·Filed 2016·Application pending·0 cites
- 4064US2020101010A1Sublingual formulation with water-soluble cocrystals of acetylsalicylic acid with citric acid, sodium bicarbonate, and l-theanine for the treatment of acute myocardial infarctionTHEAPRIN PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4163US10376464B2Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Aug 13, 2019·0 cites·12 claims
- 4263US2013012482A1Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 4361US10548905B2Amorphous onapristone compositions and methods of making the sameCONTEXT BIOPHARMA INC·Filed 2016·Granted Feb 4, 2020·0 cites·7 claims
- 4461US9896411B2Characterization of the cocrystal products formed by metoprolol and dabigatran bases with L-theanineTHEAPRIN PHARMACEUTICALS INC·Filed 2016·Granted Feb 20, 2018·0 cites·8 claims
- 4559US12472162B2Ready-to-use, terminally sterile packaging for surgical antiseptic and method of useCAREFUSION 213 LLC·Filed 2021·Granted Nov 18, 2025·0 cites·19 claims
- 4639US2014171515A1Compositions and methods for transmucosal absorptionTONIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Harry G. Brittain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →